IL6 and glioblastoma: These studies suggest that MAP4K1 remodels cytokine‒cytokine receptor networks (including IL-6/IL-6R, IL-7/IL-7R, and IL-18/IL-18R) to sustain GBM growth and progression in a cell-autonomous manner.